Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: Densitometric, histomorphometric and microtomographic studies

Micron

Volumn 39, Issue 7, 2008, Pages 998-1007

  Libouban, Hélène ^a   Blouin, Stéphane ^a   Moreau, Marie Françoise ^a   Baslé, Michel Félix ^a   Audran, Maurice ^a,b   Chappard, Daniel ^a  

^a Universite d'Angers   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Bone histomorphometry; Disuse; DXA; MicroCT; Orchidectomy; Osteoporosis; Risedronate

Indexed keywords

BIOCHEMISTRY;

BODY COMPOSITION; BONE HISTOMORPHOMETRY; BOTULINUM NEUROTOXIN; DISUSE; DUAL ENERGY X-RAY ABSORPTIOMETRY; DXA; FAT MASS; HIND LIMBS; HISTOMORPHOMETRY; MICRO-TOMOGRAPHY; MICROCT; ORCHIDECTOMY; OSTEOPENIA; OSTEOPOROSIS; RAT MODELS; RISEDRONATE;

COMPUTERIZED TOMOGRAPHY;

BOTULINUM TOXIN; DRUG DERIVATIVE; ETIDRONIC ACID; RISEDRONIC ACID; TESTOSTERONE;

ANIMAL; ARTICLE; BODY COMPOSITION; BONE; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; HINDLIMB; HISTOLOGY; MALE; METABOLIC BONE DISEASE; ORCHIECTOMY; PATHOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; RADIOGRAPHY; RAT; WISTAR RAT;

ABSORPTIOMETRY, PHOTON; ANIMALS; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; BOTULINUM TOXINS; ETIDRONIC ACID; HINDLIMB; MALE; ORCHIECTOMY; RATS; RATS, WISTAR; TESTOSTERONE; TOMOGRAPHY, X-RAY COMPUTED;

RATTUS;

EID: 48749108520     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2007.09.006     Document Type: Article

References (50)

1. Blouin S., Gallois Y., Moreau M.F., Baslé M.F., and Chappard D. Disuse and orchidectomy have additional effects on bone loss in the aged male rat. Osteoporos. Int. 18 (2007) 85-92
2. Bross R., Casaburi R., Storer T.W., and Bhasin S. Androgen effects on body composition and muscle function: implications for the use of androgens as anabolic agents in sarcopenic states. Baillieres Clin. Endocrinol. Metab. 12 (1998) 365-378
3. Chappard D., Alexandre C., Vico L., Palle S., and Riffat G. Amputation-induced Osteoporosis: A New Model to Explore the Effects of Weightlessness on the Human Skeleton (1986), ESA Publ. Div., Noordwijk, The Netherlands
4. Chappard D., Chennebault A., Moreau M.F., Legrand E., Audran M., and Baslé M.F. Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin. Bone 28 (2001) 72-79
5. Chappard D., Legrand E., Pascaretti C., Baslé M.F., and Audran M. Comparison of eight histomorphometric methods for measuring trabecular bone architecture by image analysis on histological sections. Microsc. Res. Tech. 45 (1999) 303-312
6. Chappard D., Petitjean M., Alexandre C., Vico L., Minaire P., and Riffat G. Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts. J. Bone Miner. Res 6 (1991) 673-680
7. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., Shen J., Vinson C., Rueger J.M., and Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 (2000) 197-207
8. Edelstein S.L., and Barrett-Connor E. Relation between body size and bone mineral density in elderly men and women. Am. J. Epidemiol. 138 (1993) 160-169
9. Everts V., Korper W., Hoeben K.A., Jansen I.D.C., Bromme D., Cleutjens K.B.J.M., Heeneman S., Peters C., Reinheckel T., Saftig P., and Beertsen W. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J. Bone Miner. Res 21 (2006) 1399-1408
10. Everts V., Korper W., Jansen D.C., Steinfort J., Lammerse I., Heera S., Docherty A.J., and Beertsen W. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J. 13 (1999) 1219-1230
11. Fazzalari N.L., Forwood M.R., Smith K., Manthey B., and Herreen P. Assessment of cancellous bone quality in severe osteoarthrosis: bone mineral density, mechanics, and microdamage. Bone 22 (1998) 381-388
12. Frost H.M. The regional acceleratory phenomenon: a review. Henry Ford Hosp. Med. J. 31 (1983) 3-9
13. Harris S.T., Watts N.B., Genant H.K., McKeever C.D., Hangartner T., Keller M., Chesnut Iii C.H., Brown J., Eriksen E.F., Hoseyni M.S., Axelrod D.W., and Miller P.D. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. J. Am. Med. Assoc. 282 (1999) 1344-1352
14. Hodkinson H.M., and Brain A.T. Unilateral osteoporosis in longstanding hemiplegia in the elderly. J. Am. Geriatr. Soc. 15 (1967) 59-64
15. Ijiri K., Ma Y.F., Jee W.S.S., Akamine T., and Liang X. Adaptation of non-growing former epiphysis and metaphyseal trabecular bones to aging and immobilization in rat. Bone 17 (1995) 207S-212S
16. Ito M., Nishida A., Aoyagi K., Uetani M., Hayashi K., and Kawase M. Effects of risedronate on trabecular microstructure and biomechanical properties in ovariectomized rat tibia. Osteoporos. Int. 16 (2005) 1042-1048
17. Iwamoto J., Seki A., Takeda T., Sato Y., and Yamada H. Effects of risedronate on femoral bone mineral density and bone strength in sciatic neurectomized young rats. J. Bone Miner. Metab. 23 (2005) 456-462
18. Iwamoto J., Seki A., Takeda T., Sato Y., Yamada H., Shen C., and Yeh J. Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid. Exp. Anim. 55 (2006) 349-355
19. Iwamoto J., Yeh J.K., and Takeda T. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. J. Bone Miner. Res. 18 (2003) 776-783
20. Jee W.S.S., and Ma Y. Animal models of immobilization osteopenia. Morphologie 83 (1999) 25-34
21. Kannus P., Jarvinen M., Sievanen H., Jarvinen T.A., Oja P., and Vuori I. Reduced bone mineral density in men with a previous femur fracture. J. Bone Miner. Res. 9 (1994) 1729-1736
22. Katznelson L., Finkelstein J.S., Schoenfeld D.A., Rosenthal D.I., Anderson E.J., and Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J. Clin. Endocrinol. Metab. 81 (1996) 4358-4365
23. Kaufman J.M., and Vermeulen A. Declining gonadal function in elderly men. Baillieres Clin. Endocrinol. Metab. 11 (1997) 289-309
24. Kontogianni M.D., Dafni U.G., Routsias J.G., and Skopouli F.N. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J. Bone Miner. Res. 19 (2004) 546-551
25. Lau E.M., and Cooper C. Risk factors for osteoporosis in Europe. J. Bone Miner. Metab. 19 (2001) 142-145
26. Legrand E., Chappard D., Insalaco P., Simon Y., Baslé M.F., and Audran M. Trabecular bone microarchitecture is related to clinical risk factors in osteoporosis in men (abstract). Osteoporos. Int. 13S (2002) 45
27. Legrand E., Hedde C., Gallois Y., Degasne I., Boux de Casson F., Mathieu E., Baslé M.F., Chappard D., and Audran M. Osteoporosis in men: a potential role for the sex hormone binding globulin. Bone 29 (2001) 90-95
28. Li C.Y., Price C., Delisser K., Nasser P., Laudier D., Clement M., Jepsen K.J., and Schaffler M.B. Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis. J. Bone Miner. Res. 20 (2005) 117-124
29. Li Q.N., Jee W.S.S., Ma Y.F., Ke H.Z., Xie H., Huang L.F., and Liang L.F. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in OVX rats. Bone 17 (1995) 261S-266S
30. Libouban H., Moreau M.F., Baslé M.F., Audran M., and Chappard D. Comparison insight dual X-ray absorptiometry (DXA), histomorphometry, ash weight and morphometric indices for bone evaluation in an animal model of male osteoporosis (the orchidectomized rat). Calcif. Tissue Int. 68 (2001) 31-37
31. Libouban H., Moreau M.F., Baslé M.F., Bataille R., and Chappard D. Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone 33 (2003) 283-292
32. Libouban H., Moreau M.F., Legrand E., Audran M., Baslé M.F., and Chappard D. Comparison of histomorphometric descriptors of bone architecture with dual-energy X-ray absorptiometry for assessing bone loss in the orchidectomized rat. Osteoporos. Int. 13 (2002) 422-428
33. McClung M.R., Geusens P., Miller P.D., Zippel H., Bensen W.G., Roux C., Adami S., Fogelman I., Diamond T., Eastell R., Meunier P.J., and Reginster J.Y. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N. Engl. J. Med. 344 (2001) 333-340
34. Minaire P., Neunier P., Edouard C., Bernard J., Courpron P., and Bourret J. Quantitative histological data on disuse osteoporosis: comparison with biological data. Calcif. Tissue Res. 17 (1974) 57-73
35. Mönkkönen H., Auriola S., Lehenkari P., Kellinsalmi M., Hassinen I.E., Vepsäläinen J., and Mönkkönen J. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. Br. J. Pharmacol. 147 (2006) 437-445
36. Moreau M.F., Libouban H., Legrand E., Baslé M.F., and Chappard D. Lean, fat and bone masses are influenced by orchidectomy in the rat. A densitometric X-ray absorptiometric study. J. Musculoskel. Neuron. Interact. 1 (2001) 209-213
37. Mosekilde L., Thomsen J.S., Mackey M.S., and Phipps R.J. Treatment with risedronate or alendronate prevents hind-limb immobilization-induced bone loss of bone density and strength in adult female rats. Bone 27 (2000) 639-645
38. O'Neill T.W., Felsenberg D., Varlow J., Cooper C., Kanis J.A., and Silman A.J. The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. J. Bone Miner. Res. 11 (1996) 1010-1018
39. Parfitt A.M., Mathews C.H.E., and Villanueva A.B. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J. Clin. Invest. 72 (1983) 1396-1409
40. Prior J.C., Barr S.I., Chow R., and Faulkner R.A. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 5. Physical activity as therapy for osteoporosis. CMAJ 155 (1996) 940-944
41. Rauch F., and Hamdy R. Effect of a single botulinum toxin injection on bone development in growing rabbits. J. Musculoskelet. Neuron. Interact. 6 (2006) 264-268
42. Reginster J., Minne H.W., Sorensen O.H., Hooper M., Roux C., Brandi M.L., Lund B., Ethgen D., Pack S., Roumagnac I., and Eastell R. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos. Int. 11 (2000) 83-91
43. Reid I.R., Ames R., Evans M.C., Sharp S., Gamble G., France J.T., Lim T.M.T., and Kundy T.F. Determinants of total body and regional bone mineral density in normal post-menopausal women-a key role for fat mass. J. Clin. Endocrinol. Metab. 75 (1992) 45-51
44. Taaffe D.R., Cauley J.A., Danielson M., Nevitt M.C., Lang T.F., Bauer D.C., and Harris T.B. Race and sex effects on the association between muscle strength, soft tissue, and bone mineral density in healthy elders: the Health, Aging, and Body Composition Study. J. Bone Miner. Res. 16 (2001) 1343-1352
45. Turner R., Hannon K., Demers L., Buchanan J., and Bell N. Differential effects of gonadal function on bone histomorphometry in male and female rats. J. Bone Miner. Res. 4 (1989) 557-563
46. van-den-Beld A.W., de Jong F.H., Grobbee D.E., Pols H.A., and Lamberts S.W. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J. Clin. Endocrinol. Metab. 85 (2000) 3276-3282
47. Vanderschueren D., Van Herck E., Suiker A.M., Visser W.J., Schot L.P., and Bouillon R. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology 130 (1992) 2906-2916
48. Vanderschueren D., Vandenput L., Boonen S., Van H.E., Swinnen J.V., and Bouillon R. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low, dose androgen replacement. Endocrinology 141 (2000) 1642-1647
49. Warner S.E., Sanford D.A., Becker B.A., Bain S.D., Srinivasan S., and Gross T.S. Botox induced muscle paralysis rapidly degrades bone. Bone 38 (2006) 257-264
50. Wronski T.J., and Morey-Holton E.R. Skeletal response to stimulated weightlessness: a comparison of suspension techniques. Aviation Space Env. Med. 58 (1987) 63-68